Stockreport

ImmunityBio, Inc. (IBRX): A Bull Case Theory [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio, Inc.'s share was trading at $3.9500 as of January 15th. ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies th [Read more]